Advertisements

Aurinia Pharmaceuticals Inc (AUPH) Stock Quote

Detailed Quote for Aurinia Pharmaceuticals Inc (AUPH)
$ 5.49   -0.17 (-3.00%) Volume: 1.08m 4:00 PM EST Jan 18, 2018
After Hours:  $ 5.48   -0.01 (-0.18%) Volume: 7.09k 6:51 PM EST Jan 18, 2018
Today 5d 1m 3m 1y more
Last Price
5.49
Change $
0.17
Change %
3.00%
Tick
  
Bid
5.03
Bid Size
200
Ask
5.92
Ask Size
100
Open
5.59
High
5.65
Low
5.41
Prev Close
5.66
Last Trade
01/18/18
Volume
1.08m
52 Wk Hi
10.5399999
52 Wk Low
2.38000011
Market Cap
461.44m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
84,051,758
EPS (TTM)
N/A
PE Ratio
N/A
Exchange
NSD
News and Media for Aurinia Pharmaceuticals Inc (AUPH)
Sector News | Topic News
News for Aurinia Pharmaceuticals Inc (AUPH)
Fri, Jan 05, 2018
8:10 AM Today's Research Reports on Trending Tickers: Aurinia Pharmaceuticals Inc. and INSYS Therapeutics, Inc. - ACCESSWIRE IA
Thu, Jan 04, 2018
5:38 PM After Hours Gainers / Losers - SeekingAlpha
4:37 PM Aurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus - Business Wire
Mon, Dec 11, 2017
4:02 PM Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index - Business Wire
7:45 AM Nasdaq Biotech Index: 54 to be added, 15 removed - SeekingAlpha
Wed, Nov 29, 2017
9:17 PM Addressing Concerns With Aurinia Pharmaceuticals COO Michael Martin - SeekingAlpha
Fri, Nov 24, 2017
2:02 PM 3 Reasons To Buy Aurinia Pharmaceuticals - SeekingAlpha
Thu, Nov 16, 2017
8:20 AM Today's Research Reports on Trending Tickers: Achillion Pharmaceuticals and Aurinia Pharmaceuticals - ACCESSWIRE IA
Tue, Nov 14, 2017
8:18 PM Aurinia Pharmaceuticals' (AUPH) CEO Richard Glickman on Q3 2017 Results - Earnings Call Transcript - SeekingAlpha
4:38 PM Aurinia Q3 loss widens; key trials to start next year - SeekingAlpha
4:21 PM Aurinia Pharma misses by $0.01, misses on revenue - SeekingAlpha
4:00 PM Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights - Business Wire
Mon, Nov 13, 2017
5:35 PM Notable earnings after Tuesday's close - SeekingAlpha
Wed, Nov 08, 2017
1:14 PM Aurinia Pharmaceuticals: Research, Cash Flow Projections, And 2020 Price Targets - SeekingAlpha
Mon, Nov 06, 2017
4:05 PM Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017 - Business Wire
6:20 AM Park Hotels' Yield Is Good - Cramer's Lightning Round (11/3/17) - SeekingAlpha
Mon, Oct 30, 2017
4:40 PM Aurinia Pharmaceuticals: R&D Day Update On Its Clinical Program And Pipeline Development - SeekingAlpha
Mon, Oct 23, 2017
5:38 PM After Hours Gainers / Losers - SeekingAlpha
Fri, Oct 20, 2017
8:28 AM Aurinia expands pipeline programs for voclosporin; shares ahead 2% premarket - SeekingAlpha
8:00 AM Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome - Business Wire
More News for AUPH >>

Tags for Aurinia Pharmaceuticals Inc

Research stocks or mutual funds related to Aurinia Pharmaceuticals Inc by keywords or tags. Find companies that have a similar focus to AUPH. The keywords below have been associated to AUPH by either user submission or electronic means.